» Articles » PMID: 23035040

Molecular Analysis and Biochemical Classification of TDP-43 Proteinopathy

Abstract

Amyotrophic lateral sclerosis and frontotemporal lobar degeneration with TAR DNA-binding protein of 43 kDa pathology are progressive neurodegenerative diseases that are characterized by intracytoplasmic aggregates of hyperphosphorylated TAR DNA-binding protein of 43 kDa. These TAR DNA-binding protein 43 proteinopathies can be classified into subtypes, which are closely correlated with clinicopathological phenotypes, although the differences in the molecular species of TAR DNA-binding protein 43 in these diseases and the biological significance thereof, remain to be clarified. Here, we have shown that although the banding patterns of abnormally phosphorylated C-terminal fragments of TAR DNA-binding protein 43 differ between the neuropathological subtypes, these are indistinguishable between multiple brain regions and spinal cord in individual patients. Immunoblot analysis of protease-resistant TAR DNA-binding protein 43 demonstrated that the fragment patterns represent different conformations of TAR DNA-binding protein 43 molecular species in the diseases. These results suggest a new clinicopathological classification of TAR DNA-binding protein 43 proteinopathies based on their molecular properties.

Citing Articles

The Regulation of TDP-43 Structure and Phase Transitions: A Review.

Liu Y, Xiang J, Gong H, Yu T, Gao M, Huang Y Protein J. 2025; .

PMID: 39987392 DOI: 10.1007/s10930-025-10261-0.


Targeting the TDP-43 low complexity domain blocks spreading of pathology in a mouse model of ALS/FTD.

Chevalier E, Audrain M, Ratnam M, Ollier R, Fuchs A, Piorkowska K Acta Neuropathol Commun. 2024; 12(1):156.

PMID: 39363348 PMC: 11448013. DOI: 10.1186/s40478-024-01867-z.


Production and characterization of novel monoclonal antibodies against pathological human TDP-43 proteins.

Zheng X, Wang M, He Q, Chen S, Simayi D, Ma X J Neuropathol Exp Neurol. 2024; 83(8):655-669.

PMID: 38728009 PMC: 11258413. DOI: 10.1093/jnen/nlae042.


Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43.

Castellanos Otero P, Todd T, Shao W, Jones C, Huang K, Daughrity L PLoS One. 2024; 19(4):e0298080.

PMID: 38635657 PMC: 11025846. DOI: 10.1371/journal.pone.0298080.


Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids.

Scheres S, Ryskeldi-Falcon B, Goedert M Nature. 2023; 621(7980):701-710.

PMID: 37758888 DOI: 10.1038/s41586-023-06437-2.